News from thrombolytic science, llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 19, 2017, 15:11 ET TSI completa su ensayo clínico de fase I sobre la innovadora terapia trombolítica TS01

Thrombolytic Science, LLC (TSI), una empresa biotecnológica de medicina vascular centrada en la fase clínica de desarrollo, ha anunciado hoy la...


Sep 19, 2017, 09:53 ET TSI achève un essai clinique de phase 1 portant sur le TS01, nouvelle thérapie de dissolution des caillots

Thrombolytic Science, LLC (TSI), société de stade clinique spécialisée en santé vasculaire et en biotechnologies, a annoncé aujourd'hui l'achèvement...


Sep 19, 2017, 08:33 ET TSI schließt die klinische Phase-I-Studie einer neuartigen, Blutgerinnsel auflösenden Therapie, TS01, ab

Thrombolytic Science, LLC (TSI), ein Unternehmen für die klinische Entwicklung von Gefäßgesundheit und Biotechnologie, gab heute den Abschluss der...


Sep 18, 2017, 12:31 ET TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01

Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company, today announced the completion of a Phase 1 clinical...


Nov 18, 2015, 10:18 ET Thrombolytic Science to Present at Elsevier Business Intelligence's Therapeutic Area Partnership Conference in Boston

Thrombolytic Science, LLC (TSI) announced today that Alexis C. Wallace, President & Chief Executive Officer, will be presenting TSI's lead...


Jun 01, 2015, 12:42 ET Thrombolytic Science, LLC to Collaborate With National Institutes of Health to Test a Novel Thrombolytic Regimen for the Treatment of Acute Ischemic Stroke in Phase IIa Clinical Trial

Thrombolytic Science, LLC (TSI) announced today that is has entered into an agreement with the National Institutes of Health (NIH). Under a...